BHC insider transaction filings
Bausch Health Companies Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-20. Screen BHC transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-20 | 4 | Lenar Aimee J. — President, US Pharma | Sale (S): 36,827 @ $7.03 | EDGAR |
| 2026-07-20 | 4 | Lenar Aimee J. — President, US Pharma | Tax withholding (F): 5,260 @ $4.83 | EDGAR |
| 2026-07-17 | 4 | Lenar Aimee J. — President, US Pharma | Tax withholding (F): 23,395 @ $4.89 | EDGAR |
| 2026-07-15 | 4 | LEE STEVEN HYOSIG — SVP, Controller & CAO | Tax withholding (F): 3,125 @ $4.75 | EDGAR |
| 2026-07-02 | 4 | WECHSLER AMY B — Director | Grant/award (A): 1,394 @ $4.93 | EDGAR |
| 2026-07-02 | 4 | Paulson John — Director | Grant/award (A): 12,677 @ $4.93 | EDGAR |
| 2026-07-02 | 4 | LEUNG SANDRA — Director | Grant/award (A): 6,845 @ $4.93 | EDGAR |
| 2026-05-26 | 4 | Lee Frank D. — Director | Grant/award (A): 45,871 @ $0 | EDGAR |
| 2026-05-26 | 4 | GOETTLER MICHAEL — Director | Grant/award (A): 45,871 @ $0 | EDGAR |
| 2026-05-26 | 4 | ROBERTS EIRY — Director | Grant/award (A): 45,871 @ $0 | EDGAR |
| 2026-05-26 | 4 | KAVANAGH SARAH B — Director | Grant/award (A): 45,871 @ $0 | EDGAR |
| 2026-05-26 | 4 | WECHSLER AMY B — Director | Grant/award (A): 45,871 @ $0 | EDGAR |
| 2026-05-26 | 4 | Garcia Christian A — Director | Grant/award (A): 45,871 @ $0 | EDGAR |
| 2026-05-26 | 4 | Paulson John — Director | Grant/award (A): 45,871 @ $0 | EDGAR |
| 2026-05-26 | 4 | LEUNG SANDRA — Director | Grant/award (A): 45,871 @ $0 | EDGAR |
| 2026-05-26 | 4 | POWER ROBERT N — Director | Grant/award (A): 45,871 @ $0 | EDGAR |
| 2026-05-20 | 4 | Lee Frank D. — Director | Sale (S): 24,456 @ $5.43 | EDGAR |
| 2026-04-02 | 4 | WECHSLER AMY B — Director | Grant/award (A): 1,273 @ $5.40 | EDGAR |
| 2026-04-02 | 4 | Paulson John — Director | Grant/award (A): 11,574 @ $5.40 | EDGAR |
| 2026-04-02 | 4 | LEUNG SANDRA — Director | Grant/award (A): 5,946 @ $5.40 | EDGAR |
| 2026-03-03 | 4 | Carson Seana — EVP, General Counsel | Tax withholding (F): 26,326 @ $5.93 · Sale (S): 6,856 @ $5.78 · Tax withholding (F): 16,973 @ $5.95 · Other (J): 137,922 @ $5.95 · Sale (S): 4,420 @ $5.77 | EDGAR |
| 2026-03-03 | 4 | Charhon Jean-Jacques — EVP, CFO | Tax withholding (F): 49,060 @ $5.93 | EDGAR |
| 2026-03-03 | 4 | APPIO THOMAS — Chief Executive Officer, Director | Tax withholding (F): 83,093 @ $5.93 · Tax withholding (F): 83,705 @ $5.95 · Other (J): 1,137,862 @ $5.95 | EDGAR |
| 2026-02-27 | 4 | Lenar Aimee J. — EVP, US Pharma | Grant/award (A): 157,139 @ $0 · Tax withholding (F): 17,578 @ $6.04 | EDGAR |
| 2026-02-27 | 4 | Carson Seana — EVP, General Counsel | Grant/award (A): 212,350 @ $0 · Tax withholding (F): 32,211 @ $6.04 · Sale (S): 8,388 @ $5.95 | EDGAR |
| 2026-02-27 | 4 | LEE STEVEN HYOSIG — SVP, Controller & CAO | Grant/award (A): 45,868 @ $0 | EDGAR |
| 2026-02-27 | 4 | Charhon Jean-Jacques — EVP, CFO | Grant/award (A): 276,055 @ $0 · Tax withholding (F): 35,977 @ $6.04 | EDGAR |
| 2026-02-27 | 4 | APPIO THOMAS — Chief Executive Officer, Director | Grant/award (A): 815,425 @ $0 · Tax withholding (F): 116,502 @ $6.04 | EDGAR |
| 2026-02-11 | 4 | Carson Seana — EVP, General Counsel | Grant/award (A): 137,922 @ $0 | EDGAR |
| 2026-02-11 | 4 | APPIO THOMAS — Chief Executive Officer, Director | Grant/award (A): 1,137,862 @ $0 | EDGAR |
| 2026-01-02 | 4 | WECHSLER AMY B — Director | Grant/award (A): 989 @ $0 | EDGAR |
| 2026-01-02 | 4 | Paulson John — Director | Grant/award (A): 8,992 @ $0 | EDGAR |
| 2026-01-02 | 4 | LEUNG SANDRA — Director | Grant/award (A): 4,586 @ $0 | EDGAR |
| 2025-11-28 | 4 | PAULSON & CO. INC. — 10% owner | Purchase (P): 2,500,000 @ $6.25 | EDGAR |
| 2025-10-06 | 4/A | Paulson John — Director | Holdings only — no transactions reported | EDGAR |
| 2025-10-02 | 4 | WECHSLER AMY B — Director | Grant/award (A): 1,065 @ $0 | EDGAR |
| 2025-10-02 | 4 | Paulson John — Director | Grant/award (A): 9,689 @ $0 | EDGAR |
| 2025-10-02 | 4 | LEUNG SANDRA — Director | Grant/award (A): 3,673 @ $0 | EDGAR |
| 2025-09-08 | 4 | Carson Seana — EVP, General Counsel | Tax withholding (F): 51,337 @ $7.35 · Sale (S): 13,370 @ $7.31 | EDGAR |
| 2025-08-22 | 4 | Lee Frank D. — Director | Sale (S): 15,912 @ $7.66 | EDGAR |
| 2025-08-14 | 4 | Paulson John — Director | Purchase (P): 34,721,118 @ $9 | EDGAR |
| 2025-08-13 | 4 | Paulson John — Director | Purchase (P): 2,000,000 @ $6.35 · Purchase (P): 1,156,640 @ $6.88 · Purchase (P): 86,409 @ $7.06 | EDGAR |
| 2025-07-29 | 4 | GOETTLER MICHAEL — Director | Grant/award (A): 30,149 @ $0 | EDGAR |
| 2025-07-29 | 4 | LEUNG SANDRA — Director | Grant/award (A): 30,149 @ $0 | EDGAR |
| 2025-07-18 | 4 | Lenar Aimee J. — EVP, US Pharma | Grant/award (A): 30,847 @ $0 | EDGAR |
| 2025-07-16 | 4 | Lenar Aimee J. — EVP, US Pharma | Tax withholding (F): 22,736 @ $6.42 | EDGAR |
| 2025-07-15 | 4 | LEE STEVEN HYOSIG — SVP, Controller & CAO | Grant/award (A): 27,371 @ $0 | EDGAR |
| 2025-07-02 | 4 | WECHSLER AMY B — Director | Grant/award (A): 1,032 @ $0 | EDGAR |
| 2025-07-02 | 4 | Paulson John — Director | Grant/award (A): 9,384 @ $0 | EDGAR |
| 2025-07-02 | 4 | ICAHN BRETT — Director | Grant/award (A): 4,034 @ $0 | EDGAR |
Recent 8-K events — Bausch Health Companies Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-18 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-23 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-01-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-01-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BHC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →